Antimicrobial peptides: Ancient molecules as modern therapeutics?

Expert Review of Dermatology

Volumn 3, Issue 1, 2008, Pages 1-5

  Harder, Jürgen ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA DEFENSIN 2; BETA DEFENSIN 3; BETA DEFENSIN 4; BUTYRIC ACID; CATHELICIDIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; DEFENSIN; DERMCIDIN; POLYPEPTIDE ANTIBIOTIC AGENT; PSORIASIN; RIBONUCLEASE; RIBONUCLEASE VII; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; BURN INFECTION; DRUG EFFICACY; DRUG MEGADOSE; EDITORIAL; GENE THERAPY; GENETIC ASSOCIATION; HUMAN; INFECTION; INFECTION RESISTANCE; INNATE IMMUNITY; KERATINOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SKIN FUNCTION; SKIN PROTECTION; SKIN TRANSPLANTATION;

EID: 40749145162     PISSN: 17469872     EISSN: None     Source Type: Journal    
DOI: 10.1586/17469872.3.1.1     Document Type: Editorial

References (34)

1. Boman HG. Antibacterial peptides: basic facts and emerging concepts. J. Intern. Med. 254, 197-215 (2003).
2. Zasloff M, Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc. Natl Acad. Sci. USA 84, 5449-5453 (1987).
3. Oppenheim JJ, Yang D. Alarmins: chemotactic activators of immune responses. Curr. Opin. Immunol. 17, 359-365 (2005).
4. Harder J, Gläser R, Schröder JM. The role and potential therapeutical applications of antimicrobial proteins in infectious and inflammatory diseases. Endocr. Metab. Immune Disord. Drug Targets 7, 75-82 (2007).
5. Chung WO, Dale BA. Innate immune response of oral and foreskin keratinocytes: utilization of different signaling pathways by various bacterial species. Infect. Immun. 72, 352-358 (2004).
6. Harder J, Schröder JM. Psoriatic scales: a promising source for the isolation of human skin-derived antimicrobial proteins. J. Leukoc. Biol. 77, 476-486 (2005).
7. Henseler T, Christophers E. Disease concomitance in psoriasis. J. Am. Acad. Dermatol. 32, 982-986 (1995).
8. de Jongh GJ, Zeeuwen PL, Kucharekova M et al. High expression levels of keratinocyte antimicrobial proteins in psoriasis compared with atopic dermatitis. J. Invest. Dermatol. 125, 1163-1173 (2005).
9. Nomura I, Goleva E, Howell MD et al. Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J. Immunol. 171, 3262-3269 (2003).
10. Ong PY, Ohtake T, Brandt C et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N. Engl. J. Med. 347, 1151-1160 (2002).
11. Boguniewicz, M, Leung DY. 10. Atopic dermatitis. J. Allergy. Clin. Immunol. 117, S475-S480 (2006).
12. Hollox EJ, Armour JA, Barber JC. Extensive normal copy number variation of a β-defensin antimicrobial-gene duster. Am. J. Hum. Genet. 73, 591-600 (2003).
13. Aldred PM, Hollox EJ, Armour JA. Copy number polymorphism and expression level variation of the human α-defensin genes DEFA1 and DEFA3. Hum. Mol. Genet. 14, 2045-2052 (2005).
14. Fellermann K, Stange DE, Schaeffeler E et al. A chromosome 8 gene-cluster polymorphism with low human β-defensin 2 gene copy number predisposes to Crohn disease of the colon. Am. J. Hum. Genet. 79, 439-448 (2006).
15. Hollox EJ, Huffmeier U, Zeeuwen PL et al. Psoriasis is associated with increased β-defensin genomic copy number. Nat. Genet. 40(1), 23-25 (2007).
16. Yamasaki K, Schauber J, Coda A et al. Kallikrein-mediated proteolysis regulates the antimicrobial effects of cathelicidins in skin. FASEB J. 20, 2068-2080 (2006).
17. Butmarc J, Yufit T, Carson P et al. Human β-defensin-2 expression is increased in chronic wounds. Wound Repair Regen. 12, 439-443 (2004).
18. Dorschner RA, Pestonjamasp VK, Tamakuwala S et al. Cutaneous injury induces the release of cathelicidin antimicrobial peptides active against group A Streptococcus. J. Invest. Dermatol. 117, 91-97 (2001).
19. Lee KC, Eckert RL. S100A7 (Psoriasin) - mechanism of antibacterial action in wounds. J. Invest. Dermatol. 127, 945-957 (2007).
20. Sorensen OE, Thapa DR, Roupe KM et al. Injury-induced innate immune response in human skin mediated by transactivation of the epidermal growth factor receptor. J. Clin. Invest. 116, 1878-1885 (2006).
21. Bhat S, Milner S. Antimicrobial peptides in burns and wounds. Curr. Protein Pept. Sci. 8, 506-520 (2007).
22. Jacobsen F, Mittler D, Hirsch T et al. Transient cutaneous adenoviral gene therapy with human host defense peptide hCAP- 18/LL-37 is effective for the treatment of burn wound infections. Gene Ther. 12, 1494-1502 (2005).
23. Heilborn JD, Nilsson MF, Kratz G et al. The cathelicidin anti-microbial-peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium. J. Invest. Dermatol. 120, 379-389 (2003).
24. Salzman NH, Ghosh D, Huttner KM et al. Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin. Nature 422, 522-526 (2003).
25. Bals R, Weiner DJ, Meegalla RL et al. Transfer of a cathelicidin peptide antibiotic gene restores bacterial killing in a cystic fibrosis xenograft model. J. Clin. Invest. 103, 1113-1117 (1999).
26. Lee PH, Ohtake T, Zaiou M et al. Expression of an additional cathelicidin antimicrobial peptide protects against bacterial skin infection. Proc. Natl Acad. Sci. USA 102, 3750-3755 (2005).
27. Carretero M, Del Rio M, Garcia M et al. A cutaneous gene therapy approach to treat infection through keratinocyte-targeted overexpression of antimicrobial peptides. FASEB J. 18, 1931-1933 (2004).
28. Huang GT, Zhang HB, Kim D et al. A model for antimicrobial gene therapy: demonstration of human Β-defensin 2 antimicrobial activities in vivo. Hum. Gene Ther. 13, 2017-2025 (2002).
29. Smiley AK, Gardner J, Klingenberg JM et al. Expression of human Β defensin 4 in generically modified keratinocytes enhances antimicrobial activity. J. Burn Care Res. 28, 127-132 (2007).
30. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 415, 389-395 (2002).
31. Peschel A, Sahl HG. The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nat. Rev. Microbiol. 4, 529-536 (2006).
32. Zhang H, Porro, G, Orzech N et al. Neutrophil defensins mediate acute inflammatory response and lung dysfunction in dose-related fashion. Am. J. Physiol. Lung Cell. Mol. Physiol. 280, L947-L954 (2001).
33. Wehkamp J, Harder J, Wehkamp K et al. NF-κB- and AP-1-mediated induction of human β defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: a novel effect of a probiotic bacterium. Infect. Immun. 72, 5750-5758 (2004).
34. Raqib R, Sarker P, Bergman P et al. From the cover: improved outcome in shigellosis associated with butyrate induction of an endogenous peptide antibiotic. Proc. Natl Acad. Sci. USA 103, 9178-9183 (2006).